Regulatory Approval and Compliance Risks: The company operates in highly regulated markets, and failure to obtain or maintain timely regulatory approvals for new or existing products could severely impact revenue and operations.

Intense Market Competition and Pricing Pressures: LivaNova faces significant competition from both established players and new entrants in its neuromodulation and advanced circulatory support segments, which could lead to pricing pressure, reduced market share, and lower profitability.

Product Liability Claims and Litigation: The use of LivaNova's medical devices can result in product liability claims, which could lead to substantial legal costs, damages, and reputational harm, even if such claims are unfounded.